Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke

MLA

Instituto de Salud Carlos III, et al. Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1373158553&authtype=sso&custid=ns315887.

APA

Instituto de Salud Carlos III, European Commission, Ministerio de Economía y Competitividad (España), Comunidad de Madrid, Martínez-Alonso, E., Escobar-Peso, A., Aliena-Valero, A., Torregrosa, G., Chioua, M., Fernández-Serra, R., González-Nieto, D., Ouahid, Y., Salom, J. B., Masjuán, J., Marco-Contelles, J., & Alcázar, A. (2022). Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke.

Chicago

Instituto de Salud Carlos III, European Commission, Ministerio de Economía y Competitividad (España), Comunidad de Madrid, Emma Martínez-Alonso, Alejandro Escobar-Peso, Alicia Aliena-Valero, et al. 2022. “Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1373158553&authtype=sso&custid=ns315887.